https://doi.org/10.1016/j.copbio.2020.07.010
J
Johanna Chiffelle
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
23
Papers
1.0K
Citations
13
h-index
14
i10-index
Johanna Chiffelle is an academic researcher from Ludwig Cancer Research. The author has contributed to research in topics: CAR-T cell therapy research & Immunotherapy and Immune Responses & Cancer Immunotherapy and Biomarkers. The author has an h-index of 13, co-authored 20 publications.
ORCID: 0000-0002-8312-2681Papers by this author
worksT-cell repertoire analysis and metrics of diversity and clonality
2020 · Current Opinion in Biotechnology · 189 citations
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function
2024 · Nature · 174 citations
https://doi.org/10.1038/s41586-024-07352-w
Sensitive identification of neoantigens and cognate TCRs in human solid tumors
2021 · Nature Biotechnology · 96 citations
https://doi.org/10.1038/s41587-021-01072-6
TCR sequencing and cloning methods for repertoire analysis and isolation of tumor-reactive TCRs
2023 · Cell Reports Methods · 45 citations
https://doi.org/10.1016/j.crmeth.2023.100459
Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms
2024 · Nature Biotechnology · 32 citations
https://doi.org/10.1038/s41587-024-02232-0
RIP4 inhibits STAT3 signaling to sustain lung adenocarcinoma differentiation
2017 · Cell Death and Differentiation · 30 citations
https://doi.org/10.1038/cdd.2017.81
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat